ANG Lifesciences

{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "28.43",
    "chg": 1.05,
    "chgp": "3.83%",
    "dir": 1,
    "prev_price": "27.38",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE236W01016",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "2.71 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3966466",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ANGLifesciences_mojoScore_3966466.png",
        "date": "2026-04-28 10:10:21",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3949121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ANGLifesciences_mojoScore_3949121.png",
        "date": "2026-04-16 10:10:16",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Seven-Day Slide Pushes ANG Lifesciences India Ltd to 52-Week Low of Rs 17.63",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3925319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ANGLifesciences_priceRelatedfactors_3925319.png",
        "date": "2026-03-30 14:28:57",
        "description": "For the seventh consecutive session, ANG Lifesciences India Ltd has closed lower, culminating in a fresh 52-week low of Rs 17.63 on 30 Mar 2026. This sustained decline has erased 16.85% of the stock’s value over the past week, signalling persistent selling pressure amid a challenging market backdrop."
      },
      {
        "title": "Six-Day Slide Drags ANG Lifesciences India Ltd to 52-Week Low of Rs 18.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-stock-hits-52-week-low-amid-continued-downtrend-3919424",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ANGLifesciences_priceRelatedfactors_3919424.png",
        "date": "2026-03-27 12:00:24",
        "description": "For the sixth consecutive session, ANG Lifesciences India Ltd has closed lower, culminating in a fresh 52-week low of Rs 18.5 on 27 Mar 2026. This marks a 15.98% decline over this losing streak, underscoring persistent selling pressure amid broader market weakness."
      },
      {
        "title": "Five Consecutive Losses Push ANG Lifesciences India Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-falls-to-52-week-low-amidst-continued-downtrend-3916116",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ANGLifesciences_priceRelatedfactors_3916116.png",
        "date": "2026-03-25 11:08:17",
        "description": ""
      },
      {
        "title": "ANG Lifesciences Falls to 52-Week Low of Rs 19.51 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3910061",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ANGLifesciences_priceRelatedfactors_3910061.png",
        "date": "2026-03-24 10:11:40",
        "description": "For the fourth consecutive session, ANG Lifesciences India Ltd has closed lower, culminating in a fresh 52-week low of Rs 19.51 on 24 Mar 2026. This marks a significant 50.9% decline from its 52-week high of Rs 39.7, underscoring persistent selling pressure amid challenging fundamentals and market headwinds."
      },
      {
        "title": "ANG Lifesciences India Ltd Falls to 52-Week Low of Rs 21 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-stock-hits-52-week-low-amid-continued-downtrend-3908037",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ANGLifesciences_priceRelatedfactors_3908037.png",
        "date": "2026-03-23 13:29:44",
        "description": "For the third consecutive session, ANG Lifesciences India Ltd has declined, culminating in a fresh 52-week low of Rs 21 on 23 Mar 2026. This drop comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector peers."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3846755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ANGLifesciences_mojoScore_3846755.png",
        "date": "2026-02-19 10:10:50",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "ANG Lifesciences Q3 FY26: Losses Deepen Amid Persistent Revenue Decline",
        "link": "https://www.marketsmojo.com/news/result-analysis/ang-lifesciences-q3-fy26-losses-deepen-amid-persistent-revenue-decline-3842779",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ANGLifesciences_quaterlyResult_3842779.png",
        "date": "2026-02-16 14:04:34",
        "description": "ANG Lifesciences India Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹33.00 crores, reported a quarterly net loss of ₹4.75 crores for Q3 FY26 ended December 2025, marking a 61.02% sequential deterioration from the previous quarter's loss of ₹2.95 crores. On a year-on-year basis, losses expanded 8.48% from ₹5.19 crores in Q3 FY25, as the company grapples with a sustained revenue contraction and negative operating margins."
      }
    ],
    "total": 295,
    "sid": "1002820",
    "stock_news_url": "https://www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "17-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>ANG Lifesciences India Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230PB2006PLC030341</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Harshita Aggarwal <br/> Designation: Company Secretary <br/> EmailId: cs@anglifesciences.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Saruchi Gupta <br/> Designation: Chief Finnancial Officer <br/> EmailId: saruchigupta1977@gmail.com</div> </div> <div> <br/> Date: 17/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "15-Apr-2026",
      "details": "Certificate under Reg 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Price Movement In Shares",
      "datetime": "10-Apr-2026",
      "details": "This is with reference to the email communication received from BSE Limited on April 092026 seeking clarification for a significant movement in the price of the securities of the company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ANG Lifesciences India Ltd is Rated Strong Sell

2026-04-28 10:10:21

ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

ANG Lifesciences India Ltd is Rated Strong Sell

2026-04-16 10:10:16

ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Seven-Day Slide Pushes ANG Lifesciences India Ltd to 52-Week Low of Rs 17.63

2026-03-30 14:28:57

For the seventh consecutive session, ANG Lifesciences India Ltd has closed lower, culminating in a fresh 52-week low of Rs 17.63 on 30 Mar 2026. This sustained decline has erased 16.85% of the stock’s value over the past week, signalling persistent selling pressure amid a challenging market backdrop.

Read full news article

Six-Day Slide Drags ANG Lifesciences India Ltd to 52-Week Low of Rs 18.5

2026-03-27 12:00:24

For the sixth consecutive session, ANG Lifesciences India Ltd has closed lower, culminating in a fresh 52-week low of Rs 18.5 on 27 Mar 2026. This marks a 15.98% decline over this losing streak, underscoring persistent selling pressure amid broader market weakness.

Read full news article

Five Consecutive Losses Push ANG Lifesciences India Ltd to a New 52-Week Low

2026-03-25 11:08:17

Read full news article

ANG Lifesciences Falls to 52-Week Low of Rs 19.51 as Sell-Off Deepens

2026-03-24 10:11:40

For the fourth consecutive session, ANG Lifesciences India Ltd has closed lower, culminating in a fresh 52-week low of Rs 19.51 on 24 Mar 2026. This marks a significant 50.9% decline from its 52-week high of Rs 39.7, underscoring persistent selling pressure amid challenging fundamentals and market headwinds.

Read full news article

ANG Lifesciences India Ltd Falls to 52-Week Low of Rs 21 as Sell-Off Deepens

2026-03-23 13:29:44

For the third consecutive session, ANG Lifesciences India Ltd has declined, culminating in a fresh 52-week low of Rs 21 on 23 Mar 2026. This drop comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector peers.

Read full news article

ANG Lifesciences India Ltd is Rated Strong Sell

2026-02-19 10:10:50

ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

ANG Lifesciences Q3 FY26: Losses Deepen Amid Persistent Revenue Decline

2026-02-16 14:04:34

ANG Lifesciences India Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹33.00 crores, reported a quarterly net loss of ₹4.75 crores for Q3 FY26 ended December 2025, marking a 61.02% sequential deterioration from the previous quarter's loss of ₹2.95 crores. On a year-on-year basis, losses expanded 8.48% from ₹5.19 crores in Q3 FY25, as the company grapples with a sustained revenue contraction and negative operating margins.

Read full news article

View All News